Damania Pharma Ltd - Due diligence report
A 360° intelligence report on Damania Pharma Ltd: trust score, financial health, credit view, compliance, directors, growth and distress sig…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Damania Pharma Ltd — 360° Intelligence Report
Generated from MCA filings & public recordsDamania Pharma Ltd is assessed as Moderate with a Trust Score of 52/100. Damania Pharma Ltd is an active private limited indian non-government company incorporated in 1992, operating in the Chemicals sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.
Report generated on 23 Jul 2026 from the latest processed filings. Damania Pharma Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Last balance sheet is for Mar 2017 - filings overdue.
- Flagged by authority: BSE, MCA.
- Litigation present in 1 court forum(s).
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| HEMANG PRAVINCHANDRA KAPADIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAMPAT SADASHIV SONDE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SACHIN CHANDRAKANT THAKUR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PARVEZ CAVAS DAMANIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SURENDRA BABU SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 5 directors on the board.
- HEMANG PRAVINCHANDRA KAPADIA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2017 annual returnFull shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 50 · Distress 80Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 11 eventsKey Observations
Auto-generated from the data aboveWho Uses This Report
CA · CS · Banker · Investor · VendorVerify Damania Pharma Ltd before audits and certifications: compliance score 18/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Damania Pharma Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Damania Pharma Ltd - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 52/100, distress signals and MSME payment-delay disclosures - know whether Damania Pharma Ltd pays its suppliers before you extend credit terms.
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Damania Pharma Ltd - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Damania Pharma Ltd an active company?
Damania Pharma Ltd has MCA status “Active” with a compliance score of 18/100 (Caution Indicated).
Is Damania Pharma Ltd financially healthy?
Damania Pharma Ltd has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.
Should I do business with Damania Pharma Ltd?
Its overall Trust Score is 52/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Damania Pharma Ltd?
See the directors and ownership sections above for board and shareholding detail. 5 active director(s) are on record.
Does Damania Pharma Ltd have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Damania Pharma Ltd up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 18/100 (Caution Indicated).
Is it risky to lend to Damania Pharma Ltd?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.